NOVO - Jyske hæver kursmålet
-
Novo/Jyske: Godkendelse af ny diabetespille puster til kursmål
08:44
(opdateres)Jyske Bank hæver kursmålet for Novo Nordisk-aktien forud for en ventet godkendelse af den nye diabetespille, oral Semaglutid, i USA.
Jyske Bank sætter nu det langsigtede kursmål til 385 kr. fra 365 kr., fremgå det af en analyse fra banken.
I samme omgang fastholdes købsanbefalingen.
Novo Nordisk steg 0,4 pct. onsdag til 345,75 kr.
/ritzau/FINANS
Charlotte Mackeprang
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind